How to Handle an Unstable Transplant Patient in the Oral Exam
A disciplined sequence for protecting the patient first, preserving salvageable graft function, and escalating without losing diagnostic or technical structure.
Key takeaways
- Lead with immediate stabilization, team activation, and the most time-critical threat before requesting a comprehensive workup.
- Use timing and organ-specific physiology to distinguish technical, hemodynamic, immunologic, infectious, toxic, recurrent, and systemic causes.
- Do not intensify immunosuppression reflexively while vascular compromise, obstruction, leak, infection, or shock remains plausible.
- Define a response endpoint after every intervention and a threshold for imaging, biopsy, interventional treatment, exploration, graft removal, or transfer.
Immediate response
Use the first minute to protect the patient and identify the graft-threatening mechanism
- 01
Recognize and announce instability
Name shock, respiratory failure, hemorrhage, graft hypoperfusion, sepsis, neurologic deterioration, metabolic collapse, or another immediate threat.
- 02
Call for the right help
Activate anesthesia, critical care, operating room, interventional radiology, endoscopy, cardiology, infectious disease, nephrology/hepatology, blood bank, and transfer resources according to the problem.
- 03
Stabilize in parallel
Address airway, oxygenation, ventilation, circulation, access, monitoring, blood products, electrolytes, glucose, temperature, and vasopressor or inotropic support while the diagnostic pathway begins.
- 04
Protect graft perfusion and drainage
Correct hypotension, hypovolemia, excessive venous pressure, abdominal compartment physiology, obstruction, kinking, compression, and other immediately reversible threats.
- 05
Localize the failure
Use timing, operation, anatomy, hemodynamics, bedside findings, laboratory trajectory, drains, organ function, and focused imaging to identify the fastest safe definitive action.
- 06
Commit and reassess
Drain, decompress, revascularize, explore, biopsy, treat infection, modify immunosuppression, support organ function, transfer, or remove the graft as indicated; then state the response endpoint.
When did the problem begin?
Build a time-based differential without letting the clock replace physiology
| Timing | High-priority categories | Dangerous delay |
|---|---|---|
| Intraoperative or immediate | Hemorrhage, outflow/inflow failure, kinking, thrombosis, reperfusion syndrome, primary function failure, cardiopulmonary collapse, compartment physiology, anastomotic problem, ischemic injury. | Waiting for broad laboratory trends when urgent reassessment, Doppler, direct inspection, revision, or damage control is needed. |
| Early postoperative | Vascular thrombosis or stenosis, leak or obstruction, bleeding, infection, delayed function, ischemia-reperfusion injury, rejection, medication toxicity, systemic shock, technical compression. | Calling dysfunction rejection before technical and infectious causes are excluded. |
| Intermediate | Acute rejection, opportunistic infection, anastomotic stricture or leak, drug toxicity, recurrent disease, adherence problems, venous or arterial complications, PTLD. | Treating each category in isolation without considering net immunosuppression and anatomy. |
| Late | Chronic allograft injury, recurrent or de novo disease, chronic rejection, malignancy, cardiovascular/metabolic disease, infection, adherence, medication toxicity, structural complications. | Focusing only on graft laboratory values while systemic risk and patient goals deteriorate. |
Hemorrhage, distributive, cardiogenic, obstructive, and graft-related physiology
Manage shock as a simultaneous resuscitation and source-control problem
State hemodynamic goals in relation to the organ and patient rather than using a generic fluid answer. A newly transplanted kidney may be vulnerable to hypotension; a liver recipient may have severe vasoplegia, coagulopathy, right-heart stress, bleeding, or post-reperfusion physiology; an intestinal recipient may have major fluid shifts and complex abdominal pathology.
Use bedside examination, drains, operative history, echocardiography, focused ultrasound, blood counts, coagulation and fibrinogen, lactate, acid-base status, organ-specific labs, and rapid imaging only when they do not delay required operative or interventional control.
Hemorrhagic pattern
Activate blood and operative resources, correct temperature/calcium/coagulation, identify surgical versus diffuse bleeding, and define the threshold for return to the operating room or intervention.
Distributive or septic pattern
Obtain cultures without delaying therapy, start appropriate antimicrobials, achieve source control, assess donor-derived risk, and modify immunosuppression deliberately.
Cardiogenic or right-heart pattern
Use targeted echocardiography and hemodynamics, treat rhythm or ischemia, reduce excessive preload or afterload as appropriate, and escalate mechanical support or transfer when required.
Obstructive pattern
Consider tamponade, tension physiology, pulmonary embolism, abdominal compartment syndrome, venous outflow obstruction, or graft compression and intervene promptly.
Primary graft-related pattern
Assess inflow, outflow, reperfusion, organ-specific function, and systemic consequences while recognizing when graft salvage is no longer compatible with patient survival.
Kidney, liver, pancreas, and intestine
Use organ-specific rescue pathways
| Organ/problem | Immediate distinctions | Definitive escalation |
|---|---|---|
| Kidney — oliguria or rising creatinine | Hemodynamics, volume, obstruction, vascular flow, compartment/compression, delayed function, rejection, toxicity, recurrence, infection. | Urgent Doppler and decompression as indicated; revise thrombosis/kink, drain or reconstruct urinary complications, biopsy after urgent technical causes are addressed. |
| Liver — worsening labs, lactate, coagulopathy, or instability | Arterial and portal flow, venous outflow, primary nonfunction, bleeding, biliary issue, rejection, infection, cardiac/systemic causes. | Urgent Doppler/CTA/angiography or exploration; revise inflow/outflow, control bleeding, treat sepsis, consider retransplant pathway when irreversible graft failure is present. |
| Pancreas — pain, hyperglycemia, enzymes, bleeding, or sepsis | Vascular thrombosis, pancreatitis, enteric leak, hemorrhage, rejection, infection, obstruction, graft position. | Immediate imaging or exploration according to stability; thrombectomy/revision when salvageable, drainage or bowel repair, and graft pancreatectomy when patient safety requires it. |
| Intestine/multivisceral — abdominal deterioration or graft dysfunction | Inflow/outflow, ischemia, leak, obstruction, rejection, infection, graft-versus-host disease, fluid loss, abdominal compartment physiology. | Early endoscopy/biopsy and imaging when stable; urgent exploration for ischemia, leak, bleeding, or compartment problem; source control, graft resection/explantation, or retransplant evaluation as needed. |
Do not anchor
Separate technical catastrophe from immunologic injury and infection
| Feature | Technical/structural concern | Immunologic concern | Infectious concern |
|---|---|---|---|
| Timing | Often immediate or early, but stenosis, obstruction, leak, and chronic structural problems can be delayed. | Varies by organ, mechanism, immunologic risk, adherence, and time after transplant. | Varies with exposure, prophylaxis, donor-derived risk, net immunosuppression, devices, and source. |
| Key data | Flow, anatomy, pressure, drains, imaging, direct inspection, organ-specific reconstruction. | Antibody data, biopsy pattern, organ function, drug exposure, prior rejection, adherence. | Cultures/PCR/antigen/pathology, imaging, source, donor and recipient testing, epidemiology. |
| Urgent action | Restore flow, drainage, integrity, or control bleeding; explore or intervene when delay threatens graft/patient. | Obtain adequate diagnostic support while treating when severity requires; tailor mechanism-specific therapy. | Start appropriate therapy, achieve source control, communicate/report donor-derived events, and rebalance immunosuppression. |
| Dangerous error | Waiting for biopsy while vascular compromise progresses. | Treating all dysfunction as the same rejection phenotype. | Escalating immunosuppression during uncontrolled infection or failing to drain a source. |
Protect patient and graft
Balance immunosuppression during critical illness
The answer should identify the net state of immunosuppression, the suspected mechanism of graft injury, severity of infection or malignancy, cytopenias, renal and hepatic function, wound and gastrointestinal absorption, drug interactions, and the consequences of reducing each agent.
Avoid binary language such as “stop all immunosuppression” or “treat rejection aggressively” without specifying the agent, mechanism, monitoring, and competing risk. Coordinate organ-specific transplant, infectious-disease, pathology, pharmacy, and critical-care expertise while maintaining ownership of the immediate plan.
Life-threatening infection
Prioritize antimicrobials and source control, consider reduction or temporary holding of selected agents, maintain appropriate steroid coverage, monitor graft and immune injury, and reassess frequently.
Suspected severe rejection
Exclude or address urgent technical and infectious causes, obtain mechanism-defining evidence when feasible, treat according to severity and organ, and anticipate infectious, hematologic, renal, and metabolic consequences.
Malignancy or PTLD
Establish tissue diagnosis and extent, reduce immunosuppression in a controlled fashion, use organ- and disease-specific therapy, and monitor graft function and rejection risk.
Drug toxicity or interaction
Identify the causal agent and exposure, adjust or substitute deliberately, account for interacting antimicrobials and organ dysfunction, and follow both toxicity and rejection risk.
Reassessment
Define an endpoint after every intervention
- Hemodynamics, perfusion, lactate, urine output, mental status, oxygenation, and temperature are improving or trigger escalation.
- Organ-specific flow, function, drains, laboratory trajectory, imaging, biopsy, or endoscopic findings are reassessed at a stated interval.
- Bleeding, infection source, leak, obstruction, ischemia, or compartment physiology has a definitive control plan.
- The response to antimicrobials, immunologic treatment, revascularization, drainage, or reoperation is measured rather than assumed.
- A clear threshold exists for reimaging, rebiopsy, angiography, endoscopy, exploration, graft removal, retransplant evaluation, transfer, or goals-of-care discussion.
- Patient, family, donor-related stakeholders, organ partners, OPO, and regulatory/reporting pathways are updated when relevant.
Patient survival and proportional care
Recognize when graft salvage is no longer the correct priority
Transplant surgeons are trained to protect scarce grafts, but patient survival and ethically proportionate care remain primary. Irreversible graft necrosis, uncontrolled sepsis, catastrophic bleeding, nonreconstructible vascular failure, devastating neurologic injury, or multisystem collapse may require graft explantation, retransplant consideration, transition to organ support, or limits on further intervention.
A strong oral answer states the medical facts, salvage options, expected outcomes, candidacy for retransplantation, donor and allocation implications, communication plan, and appropriate ethics or palliative support. It does not frame withdrawal of futile graft-directed treatment as abandonment.
Put the framework under pressure
Practice the answer out loud—not only on paper.
Voice-first cases, adaptive examiner follow-up, imaging, complications, and structured educational feedback for transplant surgery.
Questions candidates ask
Frequently asked questions
What should I say first when a transplant patient becomes unstable?
Name the immediate threat, call for the relevant team and resources, begin airway-breathing-circulation stabilization, protect graft perfusion and drainage, and state the fastest route to definitive control. Do not begin with a long differential while shock, bleeding, ischemia, or sepsis progresses.
When should rejection be treated empirically?
That depends on organ, severity, timing, immunologic risk, available evidence, and the danger of delay. The oral-exam answer should show that urgent technical and infectious causes are being excluded or treated simultaneously and that empiric immunologic therapy has a defined rationale, monitoring plan, and reassessment endpoint.
Is graft explantation ever the correct answer?
Yes. When a graft is irreversibly nonviable or remains the source of uncontrolled hemorrhage, infection, necrosis, or systemic collapse, removing it may be necessary to save the patient. The candidate should explain salvage attempts, operative plan, recipient reconstruction or support, and retransplant implications.
Does SurgiTest reproduce TACC questions or guarantee certification?
No. SurgiTest uses original educational scenarios informed by public examination structure and accepted transplant principles. It does not solicit or reproduce secure examination content, calculate an official TACC score, predict certification, guarantee a result, or claim affiliation with or endorsement by TACC or ASTS.
Source transparency
Official references
Board requirements, dates, and candidate instructions can change. Confirm current details directly with TACC and the Board’s candidate portal.
- TACC — Oral Exam Examinee Information
- OPTN — Policies
- CDC — U.S. Public Health Service Guideline for Donor-Derived HIV, HBV, and HCV Risk
- KDIGO — Evaluation and Management of Candidates for Kidney Transplantation
- AASLD — Liver Transplantation Practice Guidance
- Banff Foundation — Central Repository for Banff Classification Resources
Continue preparing